Transcode Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Transcode Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2021 to Q3 2024.
  • Transcode Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 4, 2024 was 17.3M shares, a 14.1% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 17.3M -2.83M -14.1% Nov 4, 2024 10-Q 2024-11-14
Q2 2024 17.3M +15.2M +752% Aug 9, 2024 10-Q 2024-08-14
Q1 2024 5.81M -10M -63.3% Mar 20, 2024 10-K 2024-04-01
Q3 2023 20.1M +7.12M +54.9% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 2.03M -11M -84.4% Aug 4, 2023 10-Q 2023-08-14
Q1 2023 15.8M +2.92M +22.6% Mar 20, 2023 10-K 2023-03-31
Q3 2022 13M +72.7K +0.56% Nov 4, 2022 10-Q 2022-11-14
Q2 2022 13M Aug 5, 2022 10-Q 2022-08-15
Q1 2022 12.9M Mar 25, 2022 10-K 2022-03-31
Q4 2021 12.9M Nov 15, 2021 10-Q 2021-11-15
Q3 2021 12.9M Aug 20, 2021 10-Q 2021-08-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.